The synthetic biology frontier: engineered oncolytic viruses and viral vectors for next-generation cancer therapy and gene delivery.

Alsharedeh RH, Aljabali AAA, Obeid MA, Alqudah A, Gammoh O, Qnais E, Mishra V, Mishra Y, El-Tanani M

DOI: 10.1039/d6ra09938f
Published: 2026 Nov 9
Container: RSC advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d6ra09938f,
  title = {The synthetic biology frontier: engineered oncolytic viruses and viral vectors for next-generation cancer therapy and gene delivery.},
  author = {Alsharedeh RH and Aljabali AAA and Obeid MA and Alqudah A and Gammoh O and Qnais E and Mishra V and Mishra Y and El-Tanani M},
  year = {2026},
  journal = {RSC advances},
  doi = {10.1039/d6ra09938f},
  url = {https://doi.org/10.1039/d6ra09938f}
}

RIS

TY  - JOUR
TI  - The synthetic biology frontier: engineered oncolytic viruses and viral vectors for next-generation cancer therapy and gene delivery.
AU  - Alsharedeh RH
AU  - Aljabali AAA
AU  - Obeid MA
AU  - Alqudah A
AU  - Gammoh O
AU  - Qnais E
AU  - Mishra V
AU  - Mishra Y
AU  - El-Tanani M
PY  - 2026
JO  - RSC advances
DO  - 10.1039/d6ra09938f
UR  - https://doi.org/10.1039/d6ra09938f
ER  -

APA

RH, A., AAA, A., MA, O., A, A., O, G., E, Q., V, M., Y, M., & M, E. (2026). The synthetic biology frontier: engineered oncolytic viruses and viral vectors for next-generation cancer therapy and gene delivery.. RSC advances. https://doi.org/10.1039/d6ra09938f

Source records

pubmed · retrieved 2026-11-10T18:57:22.516Z